Moreover, after treatment of miR‐200 inhibitor, significantly reduced blood glucose, TC, TG, ALT, AST, TNF‐α and IL‐6 were found in serum of NAFLD mice (Figure 2B, C, P < .05). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.